Overlay for medication card
09642773 ยท 2017-05-09
Assignee
Inventors
Cpc classification
A61J7/04
HUMAN NECESSITIES
B65D75/327
PERFORMING OPERATIONS; TRANSPORTING
B65D25/205
PERFORMING OPERATIONS; TRANSPORTING
B65B61/025
PERFORMING OPERATIONS; TRANSPORTING
A61J2205/50
HUMAN NECESSITIES
B65D2575/367
PERFORMING OPERATIONS; TRANSPORTING
International classification
B65D75/36
PERFORMING OPERATIONS; TRANSPORTING
A61J7/04
HUMAN NECESSITIES
B65D75/32
PERFORMING OPERATIONS; TRANSPORTING
B65B61/02
PERFORMING OPERATIONS; TRANSPORTING
Abstract
An overlay is provided for a medication card of the type having a plurality of pharmaceutical products arranged in at least one row. The overlay includes a planar body having a front surface, and a plurality of openings formed in the planar body, with locations of the plurality of openings substantially corresponding to locations of the plurality of products of the medication card. The overlay further includes instructions provided on the front surface of the body for ingesting the plurality of products of the medication card.
Claims
1. A medication card assembly comprising: a medication card including a carrier sheet having a top surface, a first row of blisters, and a second row of blisters, each blister being configured to house a pharmaceutical product, the medication card being provided without key instructions including dosage instructions; and an overlay including a planar body having a front surface and a back surface, the planar body being configured to be applied to the carrier sheet of the medication card with a bottom surface of the planar body of the overlay facing the top surface of the carrier sheet of the medication card, the planar body of the overlay being sized to lie within a boundary defined by the carrier sheet of the medication card, the planar body being separate than and uncoupled with respect to the medication card, the overlay further including a plurality of openings formed in the planar body, locations of the plurality of openings substantially corresponding to locations of the first row of blisters and the second row of blisters, and key instructions provided on the front surface of the planar body for ingesting the plurality of products of the medication card, the key instructions including dosage instructions.
2. The overlay of claim 1, wherein the medication card is unprinted or partially unprinted.
3. The overlay of claim 1, wherein the key instructions further include written instructions printed on the front surface of the planar body.
4. The overlay of claim 3, wherein the key instructions further include color coded instructions printed on the front surface of the planar body.
5. The overlay of claim 4, wherein the color coded instructions includes a first color to designate a first subset of the plurality of products to be ingested during a first time period and a second color to designate a second subset of the plurality of products to be ingested during a second time period.
6. The overlay of claim 5, wherein the first color includes at least two shades of the first color to designate separate days of the week.
7. The overlay of claim 6, wherein the second color includes at least two shades of the second color to designate separate days of the week.
8. The overlay of claim 4, wherein the key instructions further include at least one symbol printed on the front surface of the planar body.
9. The overlay of claim 8, wherein the at least one symbol designates one of a first time period and a second time period.
10. The overlay of claim 1, wherein each of the plurality of openings is sized to enable a product to extend through the opening.
11. The overlay of claim 1, wherein the overlay can be configured for different dosages.
Description
BRIEF DESCRIPTION OF DRAWINGS
(1) Various aspects of at least one embodiment are discussed below with reference to the accompanying figures, which are not intended to be drawn to scale. Where technical features in the figures, detailed description or any claim are followed by references signs, the reference signs have been included for the sole purpose of increasing the intelligibility of the figures, detailed description, and claims. Accordingly, neither the reference signs nor their absence are intended to have any limiting effect on the scope of any claim elements. In the figures, each identical or nearly identical component that is illustrated in various figures is represented by a like numeral. For purposes of clarity, not every component may be labeled in every figure. The figures are provided for the purposes of illustration and explanation and are not intended as a definition of the limits of embodiments of the disclosure. In the figures:
(2)
(3)
(4)
(5)
(6)
(7)
DETAILED DESCRIPTION
(8) It is to be appreciated that embodiments of the systems and methods discussed herein are not limited in application to the details of construction and the arrangement of components set forth in the following description or illustrated in the accompanying drawings. The methods and apparatuses are capable of implementation in other embodiments and of being practiced or of being carried out in various ways. Examples of specific implementations are provided herein for illustrative purposes only and are not intended to be limiting. In particular, acts, elements and features discussed in connection with any one or more embodiments are not intended to be excluded from a similar role in any other embodiments.
(9) Also, the phraseology and terminology used herein is for the purpose of description and should not be regarded as limiting. Any references to embodiments or elements or acts of the systems and methods herein referred to in the singular may also embrace embodiments including a plurality of these elements, and any references in plural to any embodiment or element or act herein may also embrace embodiments including only a single element. References in the singular or plural form are not intended to limit the presently disclosed systems or methods, their components, acts, or elements. The use herein of including, comprising, having, containing, involving, and variations thereof is meant to encompass the items listed thereafter and equivalents thereof as well as additional items. References to or may be construed as inclusive so that any terms described using or may indicate any of a single, more than one, and all of the described terms. Any references to front and back, left and right, top and bottom, upper and lower, and vertical and horizontal are intended for convenience of description, not to limit the present systems and methods or their components to any one positional or spatial orientation.
(10) Pharmaceutical products as used herein is used interchangeably with medicinal products and includes pills, tablets, capsules, ovules, suppositories, and the like.
(11) Embodiments of the present disclosure are directed to an overlay that can be provided with an unprinted or partially or minimally printed medication card having rows of pills, capsules, tablets, ovules, or suppositories packed in the medication card. As used herein, pharmaceutical or medicinal products in the form of pills, capsules, tablets and the like are used interchangeably and not meant to be limiting. The overlay is provided to provide the consumer instructions for the dosage for ingestion of the pills, capsules or tablets for treatment or the dosage for administration of the ovules or suppositories. As will be apparent as the description of the overlay proceeds, the medication card can be provided in a predetermined format, e.g., four rows of seven pills, capsules or tablets in each row, without any markings or other indicia provided to inform the consumer of dosage instructions, for example. With the overlay, the pharmacy can provide one of several overlays having specific instructions on the overlay for the consumer, thereby enabling the manufacture to mass produce the medication cards without customer-specific or country-specific instructions. The medication card can be unprinted or partially printed. By referencing partially printed medication card, some key instructions for the patient are not printed on the card. An example of a key instruction is dosage instructions. The key instructions are provided instead on the overlay.
(12) Referring to the drawings, and more particularly to
(13) A typical blister includes a formed sheet having a plurality of cavities or pockets formed in the sheet that are designed to receive pharmaceutical or medicinal products. The blister further includes the pharmaceutical products.
(14) It should be noted that the provision of a blister 14 having seven pills should not be considered as a limitation to the scope of the present disclosure. Seven pills may be a desired amount, representing a single pill to be taken during a single day. The medication card 10 can be provided with any number of pills depending on the intended use of the medicine. Moreover, as mentioned, the pharmaceutical or medicinal compositions can take any number of forms beyond pills, such as capsules and tablets, for example.
(15) As shown, the medication card 10 is generally rectangular in construction having chamfered corners to present an attractive package. In one embodiment, the medication card 10 can be folded in a traditional manner to fit inside an outer card or cover, which together constitutes a wallet for the consumer. It should be noted the medication card 10 can embody any number of different shapes and forms and fall within the scope of the present disclosure. As shown, the carrier sheet 12, which may be fabricated from heavy stock paper or cardboard material, or some other suitable flexible material, such as plastic sheet material. The carrier sheet 12 is generally blank in that it has no printing on the surface of the carrier sheet facing the consumer prior to the consumer removing a pill in a traditional manner or the carrier sheet can be partially printed in the manner described herein. In some embodiments, it should be noted that the medication card can include information in small print that is related to a stock number of the medication card or an expiration date of the pills contained within the medication card.
(16) Referring specifically to
(17) The overlay 20 further has a plurality of openings, each indicated at 26, formed in the planar body 22, with locations of the openings substantially corresponding to locations of the pills of the medication card. In the shown embodiment, the overlay 20 has twenty-eight openings 26 formed in the planar body 22, with four rows of seven openings corresponding to the locations of the pills of the blisters 14. Each opening 26 is sized to enable a pill to extend through the opening 26 to expose the pill to the consumer so that the consumer can apply pressure on the pill to release it from the medication card 10 in a traditional manner.
(18) As shown, the overlay 20 further includes instructions provided on a front surface 28 of the planar body 22 of the overlay. The instructions are provided for the consumer, and may include dosage instructions for ingesting the pills provided on the medication card 10. The instructions can include written instructions, e.g., written instructions 30, printed on the front surface 28 of the planar body 22. For example, the written instructions provided on the overlay 20 can include requirements for ingesting the pills, such as Always take with a glass of water on an empty stomach (at least 1 hour prior to a meal and at least 2 hours after a meal). The written instructions can further include dosage amounts, such as 40 mg daily dose. Moreover, the written instructions can include text on how the pills are removed from the medication card 10, such as Press gently on top or bottom of capsule (not middle).
(19) The type of text provided on the overlay depends of the medicine contained by the medication card 10, the dosage amount to be ingested by the consumer, and recommendations on how to remove the pills from the medication card. For example, the days of the week may be further printed on the front surface 28 of the planar body 22 of the overlay 20 to assign a certain day to a single pill. In the shown embodiment, the truncated representations of the days of the week are provided on the front surface 28 of the overlay 20, i.e., Sun, Mon, Tue, Wed, Thu, Fri, and Sat.
(20) The instructions can further include color coded instructions printed on the front surface 28 of the planar body 22 of the overlay 20. In a particular embodiment, the color coded instructions includes a first color 32 to designate a first subset of the plurality of pills to be ingested during a first time period and a second color 34 to designate a second subset of the plurality of pills to be ingested during a second time period. For example, the first color 32 can designate that a pill is to be ingested during the morning or AM hours and the second color 34 can designate that another pill is to be ingested during the evening or PM hours. In one embodiment, the first color 32 can be orange or yellow and designate an upper row of pills provided on the medication card, e.g., fourteen pills. The second color 34 can be blue or black and designate a lower row of pills provided on the medication card, e.g., another fourteen pills. It should be noted that any contrasting color may be used to designate a select group or groups of pills to be ingested at a particular time.
(21) In another embodiment, the first color 32 can include at least two shades of the first color to designate separate days of the week. Similarly, the second color 34 includes at least two shades of the second color to designate separate days of the week. As shown, the two shades of the first color 32 include a darker shade of orange and a lighter shade of orange, with the different shades of orange representing different days of the week for the morning dosage. Likewise, the two shades of the second color 34 include a darker shade of blue and a lighter shade of blue, with the different shades of blue representing different days of the week for the evening dosage. In the shown embodiment, each shade of a single color represents a separate, adjacent day of the week. For example, a darker shade of orange designates Mon or Monday and an adjacent lighter shade of orange designates Tue or Tuesday. Similarly, a darker shade of blue designates Mon or Monday and an adjacent lighter shade of blue designates Tue or Tuesday. The number of shaded columns may depend on the amount of pills to be ingested at a particular time from the blister 14.
(22) In another embodiment, the instructions can further include one or more symbols printed on the planar body. As shown, one symbol indicated at 36 designates a first time period and another symbol indicated at 38 designates a second time period. In the shown embodiment, the first symbol 36 designates morning or AM dosage and the second symbol 38 designates evening or PM dosage. Another symbol, indicated at 40, can be provided to show the consumer how to remove a pill from the medication card 10. Any number of symbols can be provided to instruct the consumer on any number of activities related to ingesting the medicine provided in the medication card within predetermined dosage amounts.
(23) Referring to
(24)
(25)
(26) Referring to
(27) In a certain embodiment, the overlay of embodiments of the present disclosure can be used in connection with an outer card that is used to store a folded medication card and overlay. The overlay can be provided with or separate from the medication card and outer card.
(28) Thus, it should be observed that the overlay of embodiments of the present disclosure is particularly effective in achieving a balanced approach in providing instructions to consumers of medicine by maximizing packaging efficiency while preserving a compliant packaging offered by a capsule wallet package and minimizing the number of variables provided by commercially-available packaging techniques. The overlay enables unprinted or partially printed medication cards to be used to dispense a variety of dosage options. The overlay can be adapted to any number of medication card configurations, thereby enabling manufacturers to produce such cards without instructions.
(29) The overlay of embodiments of the present disclosure can also be applied by pharmacists but also by patients. For example, the pharmacist can apply the overlay on the medication card or the overlay can be provided with the medicine card for application by the patient or the caregiver of the patient.
(30) Having thus described several aspects of at least one embodiment of this disclosure, it is to be appreciated various alterations, modifications, and improvements will readily occur to those skilled in the art. Such alterations, modifications, and improvements are intended to be part of this disclosure, and are intended to be within the spirit and scope of the disclosure. Accordingly, the foregoing description and drawings are by way of example only.